FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116831485> ?p ?o ?g. }

• W2116831485 endingPage "2481" @default.
• W2116831485 startingPage "2475" @default.
• W2116831485 abstract "OBJECTIVE: Refractory ascites is a debilitating condition in patients with cirrhosis. Recently, docarpamine, an orally active dopamine prodrug, was reported to increase renal blood flow, glomerular filtration, and sodium excretion. This suggests docarpamine may be useful for the treatment of refractory ascites. METHODS: In this study, we investigated docarpamine metabolism in cirrhotic patients and its effect on refractory ascites. RESULTS: Blood samples were obtained from seven cirrhotic patients and six healthy subjects after administration of 750 mg docarpamine, and plasma levels of free dopamine were measured. In healthy subjects, maximum plasma concentration (Cmax), time taken to reach Cmax (Tmax), elimination half-life (T1/2), and area under the plasma concentration-time curve (AUC) of plasma free dopamine were 76.8 ± 24.1 ng/ml, 1.3 ± 0.2 h, 0.8 ± 0.1 h, and 97.5 ± 21.1 ng · h /ml, respectively. In patients with cirrhosis, Cmax (53.1 ± 24.9 ng/ml), T1/2 (0.8 ± 0.1 h), and AUC (100.6 ± 45.6 ng · h /ml) were no different from healthy subjects when comparing each parameter, whereas Tmax (2.7 ± 0.2) was significantly longer than that of healthy subjects. We treated 10 cirrhotic patients with refractory ascites with docarpamine or placebo and the same dose of diuretics used before hospitalization. After 8 wk of docarpamine treatment, ascites disappeared completely in three of the five patients and decreased in the remainder. However, in five patients treated with placebo, ascites was not changed or increased. Side effects were not observed in any case. CONCLUSIONS: Docarpamine was found to metabolize in cirrhotic patients as well as in normal subjects and may be an effective treatment for refractory ascites." @default.
• W2116831485 created "2016-06-24" @default.
• W2116831485 creator A5004020044 @default.
• W2116831485 creator A5009422123 @default.
• W2116831485 creator A5017067098 @default.
• W2116831485 creator A5041589846 @default.
• W2116831485 creator A5051395702 @default.
• W2116831485 creator A5074832977 @default.
• W2116831485 creator A5080915286 @default.
• W2116831485 creator A5085040360 @default.
• W2116831485 creator A5087577747 @default.
• W2116831485 date "1999-09-01" @default.
• W2116831485 modified "2023-09-27" @default.
• W2116831485 title "Effects of A New Orally Active Dopamine Prodrug, Docarpamine, on Refractory Ascites: A Pilot Study" @default.
• W2116831485 cites W1967892422 @default.
• W2116831485 cites W2001137775 @default.
• W2116831485 cites W2001616815 @default.
• W2116831485 cites W2014877638 @default.
• W2116831485 cites W2048862090 @default.
• W2116831485 cites W2051837913 @default.
• W2116831485 cites W2060123467 @default.
• W2116831485 cites W2079993971 @default.
• W2116831485 cites W2083368319 @default.
• W2116831485 cites W2120179295 @default.
• W2116831485 cites W2154550325 @default.
• W2116831485 cites W2275396273 @default.
• W2116831485 cites W2295808757 @default.
• W2116831485 cites W2322491090 @default.
• W2116831485 cites W2337592240 @default.
• W2116831485 cites W2523715397 @default.
• W2116831485 doi "https://doi.org/10.1111/j.1572-0241.1999.01379.x" @default.
• W2116831485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10484011" @default.
• W2116831485 hasPublicationYear "1999" @default.
• W2116831485 type Work @default.
• W2116831485 sameAs 2116831485 @default.
• W2116831485 citedByCount "4" @default.
• W2116831485 crossrefType "journal-article" @default.
• W2116831485 hasAuthorship W2116831485A5004020044 @default.
• W2116831485 hasAuthorship W2116831485A5009422123 @default.
• W2116831485 hasAuthorship W2116831485A5017067098 @default.
• W2116831485 hasAuthorship W2116831485A5041589846 @default.
• W2116831485 hasAuthorship W2116831485A5051395702 @default.
• W2116831485 hasAuthorship W2116831485A5074832977 @default.
• W2116831485 hasAuthorship W2116831485A5080915286 @default.
• W2116831485 hasAuthorship W2116831485A5085040360 @default.
• W2116831485 hasAuthorship W2116831485A5087577747 @default.
• W2116831485 hasConcept C108215921 @default.
• W2116831485 hasConcept C112705442 @default.
• W2116831485 hasConcept C121332964 @default.
• W2116831485 hasConcept C126322002 @default.
• W2116831485 hasConcept C134018914 @default.
• W2116831485 hasConcept C142424586 @default.
• W2116831485 hasConcept C142724271 @default.
• W2116831485 hasConcept C204787440 @default.
• W2116831485 hasConcept C22979827 @default.
• W2116831485 hasConcept C27081682 @default.
• W2116831485 hasConcept C2777056448 @default.
• W2116831485 hasConcept C2777214474 @default.
• W2116831485 hasConcept C2780496750 @default.
• W2116831485 hasConcept C71924100 @default.
• W2116831485 hasConcept C76318530 @default.
• W2116831485 hasConcept C87355193 @default.
• W2116831485 hasConcept C90924648 @default.
• W2116831485 hasConcept C98274493 @default.
• W2116831485 hasConceptScore W2116831485C108215921 @default.
• W2116831485 hasConceptScore W2116831485C112705442 @default.
• W2116831485 hasConceptScore W2116831485C121332964 @default.
• W2116831485 hasConceptScore W2116831485C126322002 @default.
• W2116831485 hasConceptScore W2116831485C134018914 @default.
• W2116831485 hasConceptScore W2116831485C142424586 @default.
• W2116831485 hasConceptScore W2116831485C142724271 @default.
• W2116831485 hasConceptScore W2116831485C204787440 @default.
• W2116831485 hasConceptScore W2116831485C22979827 @default.
• W2116831485 hasConceptScore W2116831485C27081682 @default.
• W2116831485 hasConceptScore W2116831485C2777056448 @default.
• W2116831485 hasConceptScore W2116831485C2777214474 @default.
• W2116831485 hasConceptScore W2116831485C2780496750 @default.
• W2116831485 hasConceptScore W2116831485C71924100 @default.
• W2116831485 hasConceptScore W2116831485C76318530 @default.
• W2116831485 hasConceptScore W2116831485C87355193 @default.
• W2116831485 hasConceptScore W2116831485C90924648 @default.
• W2116831485 hasConceptScore W2116831485C98274493 @default.
• W2116831485 hasIssue "9" @default.
• W2116831485 hasLocation W21168314851 @default.
• W2116831485 hasLocation W21168314852 @default.
• W2116831485 hasOpenAccess W2116831485 @default.
• W2116831485 hasPrimaryLocation W21168314851 @default.
• W2116831485 hasRelatedWork W1499844227 @default.
• W2116831485 hasRelatedWork W1973465424 @default.
• W2116831485 hasRelatedWork W2036261452 @default.
• W2116831485 hasRelatedWork W2122366492 @default.
• W2116831485 hasRelatedWork W2319791043 @default.
• W2116831485 hasRelatedWork W2332994425 @default.
• W2116831485 hasRelatedWork W2397453609 @default.
• W2116831485 hasRelatedWork W2977914443 @default.
• W2116831485 hasRelatedWork W3030602471 @default.
• W2116831485 hasRelatedWork W4311614787 @default.
• W2116831485 hasVolume "94" @default.

• next